KEY: companies and medicines worldwide

Loading your page…

Sources and licences

Medicine	Substance	Country	Status	Authorised
GENAPAX5MG · Tampon	Methylrosaniline	United States	Not marketed	1977
QUINORA200mg \| 300mg · Tablet	Quinidine	United States	Not marketed
TREZIX320.5mg; 30mg; 16mg · Capsule	Paracetamol, Caffeine, Dihydrocodeine	United States	Not marketed	2014
ZONTIVITY2.08mg base · Tablet	Vorapaxar	United States	Not marketed	2014
NITRO-DUR 0.3 - 60MG/15 SQ CM, 0.3MG/HR60 mg / 15 sq cm · Patch (Extended-Release)	Nitroglycerin	Canada	Cancelled	1996

Medicine	Substance	Country	Status	Authorised
GENAPAX5MG · Tampon	Methylrosaniline	United States	Not marketed	1977
QUINORA200mg \| 300mg · Tablet	Quinidine	United States	Not marketed
TREZIX320.5mg; 30mg; 16mg · Capsule	Paracetamol, Caffeine, Dihydrocodeine	United States	Not marketed	2014
ZONTIVITY2.08mg base · Tablet	Vorapaxar	United States	Not marketed	2014
NITRO-DUR 0.3 - 60MG/15 SQ CM, 0.3MG/HR60 mg / 15 sq cm · Patch (Extended-Release)	Nitroglycerin	Canada	Cancelled	1996

Country	Medicines	Current	Past	Companies
United States	4	4	0	Companies All medicines
Canada	1	0	1	Companies All medicines

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.

U.S. Food and Drug Administration (Drugs@FDA, openFDA)

Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.

Licence: Public domain (U.S. Government work)

Health Canada, Canada

Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; October 2026 published list; https://assets.publishing.service.gov.uk/media/6ac65fc6f1ba855cc196a8ba/New_Manufacturing_and_Wholesale_Dealer_Licences_-_October_2026.csv; acquired 2026-10-14T16:17:18.644817+00:00; CSV-to-licence-event projections are adaptations under OGL v3.0.

Licence: Open Government Licence v3.0; Crown copyright MHRA published licence history

Report an error or request removalCorrections from the company itself are welcome.

KEY

Group structure

Canada2

United States2

United Kingdom1

Medicines

Know your medicines, with the sources.

KEY

Group structure

Canada2

United States2

United Kingdom1

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Other big groups

Group structure

🇨🇦Canada2

🇺🇸United States2

🇬🇧United Kingdom1

Medicines

Know your medicines, with the sources.

Group structure

🇨🇦Canada2

🇺🇸United States2

🇬🇧United Kingdom1

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Canada2

United States2

United Kingdom1

Canada2

United States2

United Kingdom1